Latent class analysis identifies distinct phenotypes of primary graft dysfunction after lung transplantation

Chest

Volumn 144, Issue 2, 2013, Pages 616-622

  Shah, Rupal J ^a   Diamond, Joshua M ^a   Cantu, Edward ^a   Lee, James C ^a   Lederer, David J ^b   Lama, Vibha N ^c   Orens, Jonathan ^d   Weinacker, Ann ^e   Wilkes, David S ^f   Bhorade, Sangeeta ^g   Wille, Keith M ^h   Ware, Lorraine B ⁱ   Palmer, Scott M ^j   Crespo, Maria ^k   Localio, A Russell ^a   Demissie, Ejigayehu ^a   Kawut, Steven M ^a   Bellamy, Scarlett L ^a   Christie, Jason D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Columbia University College of Physicians and Surgeons ^*  (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STANFORD UNIVERSITY   (United States)

^f INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h University of Alabama at Birmingham   (United States)

ⁱ VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^j DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; CONSTRUCT VALIDITY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT RECIPIENT; HUMAN; LATENT CLASS ANALYSIS; LUNG ARTERY PRESSURE; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MULTICENTER STUDY; ORGAN DONOR; PHENOTYPE; PRACTICE GUIDELINE; PREDICTIVE VALIDITY; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL;

EID: 84881519625     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-1480     Document Type: Article

References (19)

1. Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest. 2003; 124 (4): 1232-1241.
2. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D; ISHLT Working Group on Primary Lung Graft Dysfunction. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: defi nition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005; 24 (10): 1454-1459.
3. Christie JD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: Twenty-eighth Adult Lung and Heart-Lung Transplant Report-2011. J Heart Lung Transplant. 2011; 30(10): 1104-1122.
4. Dahlberg PS, Prekker ME, Herrington CS, Hertz MI, Park SJ. Medium-term results of extracorporeal membrane oxygenation for severe acute lung injury after lung transplantation. J Heart Lung Transplant. 2004; 23 (8): 979-984.
5. Christie JD, Bellamy S, Ware LB, et al. Construct validity of the defi nition of primary graft dysfunction after lung transplantation. J Heart Lung Transplant. 2010; 29 (11): 1231-1239.
6. Daud SA, Yusen RD, Meyers BF, et al. Impact of immediate primary lung allograft dysfunction on bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 2007; 175 (5): 507-513.
7. Cypel M, Yeung JC, Liu M, et al. Normothermic ex vivo lung perfusion in clinical lung transplantation. N Engl J Med. 2011; 364 (15): 1431-1440.
8. Conaway, M. Latent class analysis. In: Armitage P, Colton T, eds. Encyclopedia of Biostatistics. Hoboken, NJ: John Wiley & Sons Inc; 2005.
9. Diamond JM, Kawut SM, Lederer DJ, et al; Lung Transplant Outcomes Group. Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction. Am J Transplant. 2011; 11 (3): 561-567.
10. Diamond JM, Lederer DJ, Kawut SM, et al; Lung Transplant Outcomes Group. Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fi brosis. Am J Transplant. 2011; 11 (11): 2517-2522.
11. Fang A, Studer S, Kawut SM, et al; Lung Transplant Outcomes Group. Elevated pulmonary artery pressure is a risk factor for primary graft dysfunction following lung transplantation for idiopathic pulmonary fi brosis. Chest. 2011; 139(4): 782-787.
12. Hoffman SA, Wang L, Shah CV, et al; Lung Transplant Outcomes Group. Plasma cytokines and chemokines in pri mary graft dysfunction post-lung transplantation. Am J Transplant. 2009; 9 (2): 389-396.
13. Kiley JP. Advancing respiratory research. Chest. 2011; 140 (2): 497-501.
14. Christie JD, Shah CV, Kawut SM, et al; Lung Transplant Outcomes Group. Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med. 2009; 180 (10): 1010-1015.
15. Covarrubias M, Ware LB, Kawut SM, et al; Lung Transplant Outcomes Group. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant. 2007; 7(11): 2573-2578.
16. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999; 8 (1): 3-15.
17. Kuntz CL, Hadjiliadis D, Ahya VN, et al. Risk factors for early primary graft dysfunction after lung transplantation: a registry study. Clin Transplant. 2009; 23 (6): 819-830.
18. Gammie JS, Cheul Lee J, Pham SM, et al. Cardiopulmonary bypass is associated with early allograft dysfunction but not death after double-lung transplantation. J Thorac Cardiovasc Surg. 1998; 115 (5): 990-997.
19. The Acute Respiratory Distress Syndrome Network. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000; 342 (18): 1301-1308.